abstract |
A pharmaceutical composition in the form of a substantially amorphous solid solution comprising an antifungal compound of the formula I: wherein: X is F; and R1 is or an ester or ether of said compound of Formula I; and a soluble or insoluble polymer such as: povidone or crospovidone, wherein the ratio of said compound to said polymer is about 1:3 to about 1:6 is disclosed. |